PDV MedTech, an INDO-MIM company and a leading U.S.-based medical device design, development and manufacturing organization, and Corscience GmbH & Co. KG, a Germany-based developer of safety-critical medical technologies, have announced a strategic partnership to give medtech innovators an end-to-end path from early-stage development to manufacturing and commercialization. The alliance combines Corscience’s deep engineering expertise in complex medical devices with PDV MedTech’s U.S. and global manufacturing infrastructure, aiming to reduce friction, shorten timelines and expand access to specialized capabilities across Europe and the United States.
The partnership addresses common challenges in regulated device development: proximity to engineering teams, access to specialized technical expertise, design for manufacturability, regulatory readiness and scalable production. European innovators gain access to PDV MedTech’s manufacturing capabilities; U.S. companies gain Corscience’s European development expertise and proven experience with the EU MDR regulatory framework. For both companies, the arrangement extends the geographic reach by leveraging each partner’s regional networks and market expertise.
“Corscience has built its reputation on solving the hardest problems in cardiovascular and emergency medicine devices, where failure is not an option,” said Dr. Jörg Pintaske, CEO of Corscience. “Expanding into the United States is a strategic priority for us, and PDV MedTech is exactly the partner we were looking for: a company with manufacturing depth, a customer-first culture, and the global infrastructure to take a product from our development labs all the way to the bedside. We are proud to formalize this relationship and excited about what we will build together.”
The partnership offers a flexible model for companies requiring deep development expertise in safety-critical and connected devices, scalable manufacturing or a combination of both, depending on product requirements, regulatory strategy, cost targets and time-to-market priorities. Manufacturing options scale from prototype and low-volume builds in Morgan Hill and Utah, to medium- and high-volume production in San Antonio, Texas, through to global-scale manufacturing in Mexico, India and the U.K., covering the full range from first prototype to high-volume commercialization.
“For 25 years, PDV MedTech has been focused on helping innovative solutions reach the market and make a meaningful impact on patients,” said Bryant Grigsby, CEO of PDV MedTech. “The partnership gives medtech innovators a more complete path from early-stage development to manufacturing. It is designed to be more practical, more global, and more customer-driven. Together we are building the future of medtech, not just for our companies, but with our partners and customers.”
